← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 15, 2020Last known activity
Jan 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 5 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT06740045Sponsor investigatorPhase 3Jan 31, 2025
- NCT06740045Lead sponsorPhase 3Jan 31, 2025
- NCT06556264Sponsor investigatorPhase 4Aug 31, 2024
- NCT06556264Lead sponsorPhase 4Aug 31, 2024
- NCT06107101Lead sponsorPhase 4Jan 1, 2024
- NCT06107101Reponsible party - principal investigatorPhase 4Jan 1, 2024
- NCT05642806Lead sponsorPhase 4Jan 30, 2023
- NCT05642806Reponsible party - principal investigatorPhase 4Jan 30, 2023
- NCT04601324Reponsible party - principal investigatorPhase 4Dec 15, 2020
- NCT04601324Lead sponsorPhase 4Dec 15, 2020
Details
- Last known activity
- Jan 31, 2025